根据向美国证券交易委员会（SEC）提交的文件，National Health Investors 于2026年5月26日宣布，其关于设施出售交易的《哈特-斯科特-罗迪诺反托拉斯改进法案》（HSR Act）等待期已获得提前终止。
这一进展标志着交易推进过程中的一项关键监管障碍已被清除。HSR法案的等待期旨在让美国联邦贸易委员会和司法部审查交易是否可能损害市场竞争。获得提前终止，意味着监管机构在法定审查期限届满前已决定不进一步深入调查，通常被视为交易获得监管批准的积极信号。
此举为National Health Investors按计划完成其设施资产出售扫清了道路。公司通过处置非核心或特定资产，旨在优化其投资组合结构，强化资产负债表，并可能将资源重新配置于更具战略重点的领域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.